ConoGenetix biosciences Alternatives & Competitors

12 companies similar to ConoGenetix biosciences — Pioneering peptide therapeutics to combat autoimmune diseases.

Proclara Biosciences

Pioneering therapies to combat neurodegenerative diseases with innovative protein disaggre...

Venture round $115.72M

Biotechnology Health Care +2

Synta Pharmaceuticals

Innovating patient care with advanced small molecule therapies for severe medical conditio...

Post-IPO Equity $217.35M

Biotechnology Health Care +1

Anthera Pharmaceuticals

Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health

Post-IPO Equity $101.50M

Biotechnology Health Care +1

Pharmacopeia

Innovating to meet critical health challenges with advanced therapeutic discoveries and de...

Venture round $7.63M

Biopharma Biotechnology +1

Track all ConoGenetix biosciences competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Cyxone

Life-changing treatments for disorders of the immune system

Malmo, Sweden

Biotechnology Health Care

Altamira Therapeutics

Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic t...

13 Post-IPO Debt $118.68M

Hamilton, Bermuda

Health Care Health and Wellness +1

SynAct Pharma

Resolving Inflammation Through Melanocortin Biology

6 Grant $71.43K

Lund, Sweden

Biotechnology Health Care

REGiMMUNE Corporation

5 Series E $716.00M

Biopharma Biotechnology +1

Delinia

Pioneering breakthrough treatments for autoimmune and inflammatory diseases with a focus o...

3 Acquired $335.00M

San Francisco, United Sta...

Biotechnology Health and Wellness

Arvinas

Leading the way in targeted protein degradation therapeutics

305 $585.85M

New Haven, United States

Biotechnology Health Care +2

Antiverse

Designing functional antibodies for the most challenging targets.

33 Series A $21.82M

Cardiff, United Kingdom

AI Biotechnology +4

PRISM BioLab Co., Ltd.

PRISM BioLab is a biotechnology company with PepMetics Technology, a proprietary drug disc...

17 Series C $3.20B

Japan

Biopharma Biotechnology +2

About ConoGenetix biosciences

ConoGenetix biosciences is a pioneering biopharmaceutical startup established in 2002 by Dr. Andreas Klostermann and Dr. Jörg Stockhaus, with its headquarters in Martinsried, Germany.

Business keywords

Biopharmaceutical Company, Peptide Therapeutics, Autoimmune Diseases, Ion Channel Targets, Multiple Sclerosis, Rheumatoid Arthritis, Vasculitis, Preclinical Development, Integrated Technology Platform, Drug Discovery, Martinsried, Germany, Innovation, Private Ownership, Scientific Advancement

Frequently Asked Questions

Companies similar to ConoGenetix biosciences include Proclara Biosciences, Synta Pharmaceuticals, Anthera Pharmaceuticals, Pharmacopeia, Cyxone. They work in Biotechnology and Health Care and share ConoGenetix biosciences's focus on drug discovery, autoimmune diseases and rheumatoid arthritis.

Bounce Watch lists 12 companies that share ConoGenetix biosciences's industries and are closest to it in business tags, services, target customers, business model and size.

ConoGenetix biosciences is a pioneering biopharmaceutical startup established in 2002 by Dr. Andreas Klostermann and Dr. Jörg Stockhaus, with its headquarters in Martinsried, Germany.

Don't just read about them. Follow them.

BounceWatch watches ConoGenetix biosciences and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

ConoGenetix biosciences Profile Proclara Biosciences Alternatives Synta Pharmaceuticals Alternatives Anthera Pharmaceuticals Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at ConoGenetix biosciences on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.